[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352736-105":59,"doc-detail-352736-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","dissection-of-the-t-cell-infiltrate-in-mouse-pancreatic-tumors-reveals-an-extensive-and-diverse-tumor-reactive-t-cell-repertoire","Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoire","","Pancreatic ductal adenocarcinoma remains largely refractory to immune checkpoint blockade despite evidence of natural antitumor T cell immunity. This study dissects the tumor-infiltrating T cell receptor landscape in a syngeneic orthotopic murine model using single-cell transcriptomics combined with functional TCR characterization. The work identifies extensive tumor-reactive TCR clonotypes with broad reactivity patterns and defines three tumor T cell epitopes spanning distinct antigen classes, including neoantigens, retroviral provirus-derived signals, and stress-induced autoantigens, informing personalized immunotherapy potential and safety.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dissection-of-the-t-cell-infiltrate-in-mouse-pancreatic-tumors-reveals-an-extensive-and-diverse-tumor-reactive-t-cell-repertoire/352736/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dissection-of-the-t-cell-infiltrate-in-mouse-pancreatic-tumors-reveals-an-extensive-and-diverse-tumor-reactive-t-cell-repertoire/352736.png","ImageObject",300,407,{"name":92,"@type":93},"Alex Sinclair","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is pancreatic cancer challenging for immune checkpoint blockade?","Question",{"text":113,"@type":114},"Most pancreatic tumors are unresponsive to immune checkpoint blockade, and the disease is shaped by strong driver mutation pressures and barriers from the tumor microenvironment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the study characterize tumor-reactive T cell receptor clonotypes?",{"text":118,"@type":114},"It analyzed the T cell repertoire in a murine pancreatic cancer model by combining single-cell transcriptomics with functional characterization of TCR reactivity against tumor cells.",{"name":120,"@type":111,"acceptedAnswer":121},"What kinds of tumor epitopes were identified?",{"text":122,"@type":114},"Immunopeptidome analyses revealed three T cell epitopes reflecting distinct antigen classes, including a neoantigen from the mutanome, an epitope from an ectopically expressed endogenous retroviral provirus, and an epitope from a stress-induced autoantigen.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352736,1790167355,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","CANCER  \nDissection of theT cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoire  \nHannes Kehm1,2†, Stefan Zens1,2†, Daniel Baumann1,2,3, Zibo Meng1,3,4, Arnoud H. de Ru5, RaymanT. N. Tjokrodirijo5, Caroline Vent1,3, Olga Murawjew1,2, Sarah Braun1,2, Anne Weiss1,2, Florian Bieberich1,2, Aline Konrad1,2, Francesca Lucato1,6, Janne Kühner1,6,  \nSonia Gutierrez Minguez1, Chin Leng Tan1, Jonas D. Förster2,7,8, Mogjiborahman Salek7,8, Angelika B. Riemer7,8, Michael Volkmar1,9, Peter van Veelen5,  \nIsabel Poschke1,3‡§, Rienk Offringa1,3,4*‡  \nAlthough pancreatic cancer is generally refractory to immune checkpoint blockade, recent studies of tumorinfiltrating T cells in human tumor samples demonstrated the presence of in vivo expanded, tumor-reactive T cell receptor (TCR) clonotypes. Here, we explored the T cell repertoire in a murine pancreatic cancer model by combining single-cell transcriptomics with functional TCR characterization. This uncovered a substantial diversity of tumorreactive TCR clonotypes. Whereas some of these were exclusively reactive against the autologous tumor, most TCRs reacted against syngeneic tumor cells of diverse tissue origin. Immunopeptidome analyses revealed three T cellepitopes reflecting distinct tumor antigen classes also found in human cancers: a mutanome-encoded neoantigen, an epitope encoded by an ectopically expressed endogenous retroviral provirus, and an epitope derived from a cell stress– induced autoantigen. These findings underline the importance of uncovering the antigen specificity of the natural tumor-reactive TCR repertoire to assess its therapeutic potential and safety with regard to personalized immunotherapy.  \ncopyright © 2026 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution license 4.0 (cc BY) .  \nINTRODUCTION  \nDespite advances in surgical and cytostatic treatment, pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancer entities to date (1) . The lack of effective treatment options is linked to key biological aspects of this disease, including the powerful combination of driver mutations, involving activation of the KRAS oncogene and loss of the tumor suppressor function of p53, CDKN2A, and/or SMAD4, as well as the barriers imposed by the tumor microenvironment (TME) (2, 3) . Consequently, the tumor is refractory to chemotherapy and targeted therapy. Furthermore, most pancreatic tumors are unresponsive to immune checkpoint blockade (ICB)(4, 5) . Nevertheless, we and others have found evidence for natural antitumor T cell immunity in human PDAC (6–13) . More recently, we confirmed the presence of tumor-reactive (TR)-T cell receptor  \n1division of Molecular Oncology of Gastrointestinaltumors, German cancer Research center, heidelberg 69120, Germany. 2Faculty of Biosciences, heidelberg University, heidelberg 69120, Germany. 3department of General, visceral and transplantation Surgery, University hospital heidelberg, heidelberg 69120, Germany. 4Sino-German laboratory of Personalized Medicine for Pancreatic cancer, Union hospital, tongji Medical college, huazhong University of Science and technology, Wuhan, hubei 430022, china. 5center for Medical Systems Biology, leiden University Medical center, leiden, netherlands. 6Faculty of engineering, heidelberg University, heidelberg 69120, Germany. 7division of immunotherapy & immunoprevention, German cancer Research center (dKFZ), heidelberg 69120, Germany. 8Molecular vaccine design, German center for infection Research (dZiF), partner site heidelberg, heidelberg 69120, Germany. 9tcR discovery Platform, helmholtz-institute for translational Oncology by dKFZ (hi-tROn), Mainz 55131, Germany.  \n*[corresponding author. email: r.offringa@dkfz-heidelberg.de](corresponding author. email: r.offringa@dkfz-heidelberg.de)[ ](cor","cbCaipGkAXX3tfiy","https://ap.wps.com/l/cbCaipGkAXX3tfiy","pdf",9049464,22,"English","# Introduction\n## Rationale for studying tumor-infiltrating T cells in PDAC\n## Natural antitumor immunity and resistance to ICB\n# Study approach in a murine PDAC model\n## Syngeneic orthotopic model and tumor control context\n## Single-cell RNA sequencing and functional TCR testing","[{\"question\":\"Why is pancreatic cancer challenging for immune checkpoint blockade?\",\"answer\":\"Most pancreatic tumors are unresponsive to immune checkpoint blockade, and the disease is shaped by strong driver mutation pressures and barriers from the tumor microenvironment.\"},{\"question\":\"How did the study characterize tumor-reactive T cell receptor clonotypes?\",\"answer\":\"It analyzed the T cell repertoire in a murine pancreatic cancer model by combining single-cell transcriptomics with functional characterization of TCR reactivity against tumor cells.\"},{\"question\":\"What kinds of tumor epitopes were identified?\",\"answer\":\"Immunopeptidome analyses revealed three T cell epitopes reflecting distinct antigen classes, including a neoantigen from the mutanome, an epitope from an ectopically expressed endogenous retroviral provirus, and an epitope from a stress-induced autoantigen.\"}]","Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoire | PDF",1790101156,55,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a14b8529f1d80b7632111e0fc9687ead.webp",983,1250,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/612c302ffdb6822f7198b43d6e61e8f4.webp",982,1249,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5c7e82f80caaa2abf2afeaecc3a0207.webp",981,1248,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a20ac99f2ee4e4da91d090a00e4d8c4.webp",980,1247]